Correction for Suzuki et al., “Evaluation of fully automated chemiluminescent enzyme immunoassays for hepatitis B core-related antigen components, phosphorylated and non-phosphorylated hepatitis B core antigens: clinical significance and dynamics during hepatitis B e antigen seroconversion”
Takanori Suzuki, Yasuhito Tanaka, Osamu Arai(Hokkaido University), Takako Inoue(Kaneka (United States)), Chiharu Ohue(Advanced Life Science Institute), Shintaro Ogawa(Nagoya City University), Kentaro Matsuura, Shintaro Yagi, Katsuya Nagaoka(Kumamoto University), Yuka Inose, Katsumi Aoyagi(Fujirebio (Japan))
Cited by 0
Related Papers
Gut Dysbiosis Associated With Hepatitis C Virus Infection
|Clinical Infectious Diseases|2018|187
Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: Newborn screening and its relationship to the diagnosis and treatment of the disorder
|Screening|1993|161
Hepatitis B virus and its sexually transmitted infection – an update
|Microbial Cell|2016|131
Novel biomarkers for the management of chronic hepatitis B
|Clinical and Molecular Hepatology|2020|128
Clinical efficacy of a novel, high-sensitivity HBcrAg assay in the management of chronic hepatitis B and HBV reactivation
|Journal of Hepatology|2021|112